Below are my publications, including peer-reviewed articles, reviews, and manuscripts currently under review/revision​. If you're interested in any of these works or potential collaborations, feel free to reach out.

• Liu, Y., Zhou, J., Wang, Y., Nguyen, D., Baskaran, D., Liu, Y., & Wang, H. (2025). RENBP inhibition amplifies metabolic glycan labeling efficiency of antigen-presenting cells in vitro and in vivo.Cell Chemical Biology. 
• Liu, Y., Zhou, J., Wang, Y., Baskaran, D., Wang, H. Unnatural Lipids for Simultaneous mRNA Delivery and Metabolic Cell Labeling. Biomaterials Science 2024, 12(16), 4170-4180.
• Liu, Y., & Wang, H. Biomarkers and targeted therapy for cancer stem cells. Trends in Pharmacological Sciences 2023, 45, 56-66.
• Liu, Y., Han, J., Bo, Y., Bhatta, R., & Wang, H. Targeted delivery of liposomal chemoimmunotherapy for cancer treatment. Frontiers in Immunology 2022, 13, 6031.
• Zhou, J., Liu, Y., Xu, W., Bhatta, R., Han, J., Baskaran, D., ... & Wang, H. (2025). Macroporous Hydrogel-Based mRNA Cancer Vaccine for In Situ Recruitment and Modulation of Dendritic Cells. Acta Biomaterialia.
  
• Baskaran, D., Liu, Y., Zhou, J., Wang, Y., Nguyen, D., & Wang, H. (2025). In Vitro and In Vivo Metabolic Tagging and Modulation of Platelets. Materials Today Bio, 101719.
• Dwivedy A, Baskaran D, Sharma G, Hong W, Gandavadi D, Krissanaprasit A, Han J, Liu Y, Zimmers Z, Mafokwane T, Hayah I, Chauhan N, Zheng M, Yao S, Fraser K, Decker J, Jin X, Wang H, Friedman A, Wang X. Engineering Novel DNA Nanoarchitectures for Targeted Drug Delivery and Aptamer Mediated Apoptosis in Cancer Therapeutics. Advanced Functional Materials 2025.
• Bhatta R, Han J, Liu Y, Bo Y, Wang H*. Extracellular Vesicle Hydrogels with Tunable Viscoelasticity and Injectability for Depot Vaccines. Nature Communications 2025. Accepted.
• Bo, Y., Wang, Y., Han, J., Bhatta, R., Liu, Y., Baskaran, D., Zhou. J., Wang, H. Primary Adipocytes as Targetable Drug Depot to Prevent Post-Surgical Cancer Recurrence. Materials Today Bio 2024, 25, 101020.
• Han, J., Bhatta, R., Liu, Y., Bo, Y., Elosegui-Artola, A., & Wang, H. Metabolic glycan labeling immobilizes dendritic cell membrane and enhances antitumor efficacy of dendritic cell vaccine. Nature Communications 2023, 14 (1), 5049.
• Bhatta, R., Han, J., Liu, Y., Bo, Y., Lee, D., Zhou, J., ... & Wang, H. Metabolic tagging of extracellular vesicles and development of enhanced extracellular vesicle based cancer vaccines. Nature Communications 2023, 14 (1), 8047.
• Bhatta, R., Han, J., Liu, Y., Bo, Y., & Wang, H. T cell-responsive macroporous hydrogels for in situ T cell expansion and enhanced antitumor efficacy. Biomaterials 2023, 293, 121972.
• Han, J., Bhatta, R., Liu, Y., Bo, Y., & Wang, H. In Situ Dendritic Cell Recruitment and T Cell Activation for Cancer Immunotherapy. Frontiers in Pharmacology 2022, 13, 954955.
• Han, J., Park, J., Bhatta, R., Liu, Y., Bo, Y., Zhou, J., & Wang, H. A double crosslinking adhesion mechanism for developing tough hydrogel adhesives. Acta Biomaterialia 2022, 150, 199-210.
• Wang, W., Hao, Y., Liu, Y., Li, R., Huang, D. B., & Pan, Y. Y. Nanomedicine in lung cancer: Current states of overcoming drug resistance and improving cancer immunotherapy. Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology 2021, 13(1), e1654.

In Revision/Under Review

• Yusheng Liu, Yizun Wang, Yueji Wang, Jiadiao Zhou, Dhyanesh Baskaran, Joonsu Han, Rimsha Bhatta, Daniel Nguyen, Fan Lam, Hua Wang*. In Vivo Metabolic Tagging and Targeting of Red Blood Cells. Nature Communications. Accepted.
• Yusheng Liu, Jiadiao Zhou, Dhyanesh Baskaran, Yueji Wang, Daniel Nguyen, Yuan Liu, Hua Wang*. RNA Antibody Abrogates the Priming of Antigen-Specific T cells and Reverses Type-1 Diabetes. Cell. Submitted.
• Kecheng Wu, Juan Mi, Zhaoji Liu, Yusheng Liu, Guiyuan Chen, Yun Xing, Zechenxi Song, Haocheng Zheng, Jillian Perry, Shaomin Tian, Xiaoyuan Chen, Yuanzeng Min1, Jianping Weng. Spleen homing multivalent nanovaccine induces immune tolerance and protects against early onset type 1 diabetes. Advaned Science. Under Review.
• Joonsu Han, Abhisek Dwivedy, Tianrui Xue,Rimsha Bhatta, Yusheng Liu, Yang Bo, Jiadiao Zhou, Yueji Wang, Joseph Irudayaraj, Shuming Nie, Xing Wang, Hua Wang. Self-Adjuvanting α-Helical Polypeptides for Potent mRNA Cancer Vaccines. Nature Communications. Under Revision.
• Yang Bo, Yueji Wang, Nilmani Singh, Joonsu Han, Jingyi Zhou, David Zhou, Rimsha Bhatta, Yusheng Liu, Dhyanesh Baskaran, Shanny Hsuan Kuo, Gee W. Lau, Huimin Zhao, Hua Wang*. Universal Transplant-Specific CAR Regulatory T Cells Prolong Transplant Survival. Nature Chemical Biology. Submitted.